U.S. REPRESENTATIVE KEN CALVERT (R-CA) CHAIRMAN HOLDS HEARING ON THE HUMAN GENOME PROJECT

From: Washington Transcript Service | Date: June 17, 1998 | Copyright information

00-00-0000
ENERGY AND ENVIRONMENT SUBCOMMITTEE OF THE HOUSE SCIENCE COMMITTEE HOLDS HEARING ON THE HUMAN GENOME PROJECT

JUNE 17, 1998

SPEAKERS: U.S. REPRESENTATIVE KEN CALVERT (R-CA), CHAIRMAN U.S. REPRESENTATIVE HARRIS W. FAWELL (R-IL) U.S. REPRESENTATIVE CURT WELDON (R-FL) U.S. REPRESENTATIVE DANA ROHRABACHER (R-CA) U.S. REPRESENTATIVE VERNON J. EHLERS (R-MI) U.S. REPRESENTATIVE MATT SALMON (R-AZ) U.S. REPRESENTATIVE MARK FOLEY (R-FL) U.S. REPRESENTATIVE PHIL ENGLISH ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

HUMAN GENOME PROJECT:KEN CALVERT
; ...sequencing of the human genome began in the...implications and our federal program is jointly run...3 billion federal program reached its...sequencing of the human genome in three years...cost of the federal program. Just how this...And will the ...
Federal pact lifts drug firm; Human Genome Sciences sells anthrax treatment.(BUSINESS)(YOUR MONEY: STOCK VIEW)
; ...Haberkorn, THE WASHINGTON TIMES Shares of Human Genome Sciences Inc. rose more than 3 percent...government with medicine to treat anthrax. Human Genome will supply 10 grams of the drug, ABthrax...order at $50 million to $200 million. Human Genome Chief Executive Officer H. Thomas ...
Pfizer deal lifts Human Genome.(BUSINESS)(YOUR MONEY: STOCK VIEW)
; ...Higgins, THE WASHINGTON TIMES Shares of Human Genome Sciences Inc. rallied yesterday after...Pfizer Inc. Pfizer last week bought from Human Genome its rights for research, development...which Pfizer acquired earlier this year. Human Genome will receive a one-time, undisclosed...
Glaxo markets diabetes drug by Rockville, Md., biotech Human Genome Sciences.
; Byline: William Patalon Iii Oct. 27--Human Genome Sciences Inc. has licensed an experimental...biotechnology firm. Separately yesterday, Human Genome announced a third-quarter net loss of...2.7 percent, to close at $9.75. For Human Genome, still struggling to make the transition...
Human Genome Makes British Deal; Md. Firm Pushing Search for Treatments
; Human Genome Sciences Inc. said yesterday that it...disease with customized antibodies. Human Genome, a Rockville gene-hunting company with...England. As part of a complex transaction, Human Genome will gain rights to important patents...
FIVE WAYS TO RIDE A WAVE; Human Genome's Tests Could Tell
; ...difficult, if not impossible, to value is Human Genome Sciences Inc. of Rockville, a pioneer...has been in business since 1992, but Human Genome is still in a start-up phase and loses...to lofty heights over the past year. Human Genome closed at an all-time record of $159...
The human genome sequence: Impact on health care
; The human genome sequence: impact on health care The recent sequencing of the human genome, resulting from two independent global efforts...target other important large genomes. The human genome sequence has revealed several novel/surprising...
Pfizer Deal Lifts Shares of Rockville, Md.-Based Human Genome Sciences.
; ...Tribune Business News Dec. 23--Shares of Human Genome Sciences Inc. rallied yesterday after...Pfizer Inc. Pfizer last week bought from Human Genome its rights for research, development...which Pfizer acquired earlier this year. Human Genome will receive a one-time, undisclosed...
98. HUMAN GENOME SCIENCES INC.
; 98. HUMAN GENOME SCIENCES INC. 9620 Medical Center...CEO) EMPLOYEES: 110 DESCRIPTION: Human Genome Sciences, a two-year-old company...DEVELOPMENTS: For such a young company, Human Genome Sciences had a big year. In May, the...
Human Genome Gains Major Research Funds; 2 Drug Firms to Provide at Least $90 Million
; Human Genome Sciences Inc. of Rockville and its major...simply too much information coming out of Human Genome's work on mapping the human genetic...and make use of. The deal should give Human Genome sufficient funding to support its research...